010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

Helmut Butzkueven, Tim Spelman, Tomas Kalincik, Katherine Buzzard, Anneke Van der Walt, Jeanette Lechner-Scott, Suzanne Hodgkinson, Ernest Butler, Richard Macdonell, Mark Slee, MSBase Study Group, Bruno Marcel